GlassScriptPhysician profile
Robert Conway
NPI 1063831394
$6,231.06
in general payments reported to CMS, 2019-2025
12 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,825 · 2022: $381 · 2023: $372 · 2024: $1,117 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,794 · Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,794.01 |
| Food and Beverage | $1,231.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,465.86 | 2021-2025 | Na, Valiant Captivia, Endurant Iis |
| W. L. Gore & Associates, INC. | $1,178.53 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Cook Medical LLC | $206.08 | 2023 | Zenith Alpha, Zenith, Zenith Spiral-Z |
| Penumbra, INC. | $123.98 | 2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $51.39 | 2023-2025 | Eluvia |
| Inari Medical, INC. | $40.97 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $40.60 | 2023 | Angiovac |
| Janssen Pharmaceuticals, INC | $27.19 | 2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $25.03 | 2022 | |
| Shockwave Medical, INC | $24.35 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $23.57 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Argon Medical Devices, INC. | $23.51 | 2024 | Clot Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.